InvestorsHub Logo
Followers 3
Posts 288
Boards Moderated 0
Alias Born 12/21/2022

Re: None

Wednesday, 03/22/2023 12:15:04 PM

Wednesday, March 22, 2023 12:15:04 PM

Post# of 3283
In today's earning call, Tom said that they are going to present data from a same-day Rolvedon trial in 2H23. It is what their R&D department is working on now, besides pediatric study. I was hoping to hear about their future pipeline but nothing was said. Looks like Rolvedon sales in 1Q23 will be OK. J-code will be in force from April 1.